){kind=logo}
)
Al Reba
Senior Vice President of Immunology & Cardiovascular Commercialization
,
Bristol Myers Squibb
Al Reba is driven by a passion for bold science and groundbreaking innovation that transforms lives. With more than 25 years at Bristol Myers Squibb (BMS), Al has dedicated his career to delivering hope and life-changing medicines to patients around the world.
In February 2025, Al was appointed Senior Vice President of Immunology & Cardiovascular Commercialization. Since joining BMS in 1999, Al has taken on roles of increasing responsibility across diverse therapeutic areas, including cardiovascular, neuroscience, metabolics, and oncology. Highlights of his career include serving as the U.S. Launch lead for a top-performing cardiovascular product in the U.S. market, General Manager of BMS Canada (2017–2021), Senior Vice President of Worldwide Cardiovascular and Established Brands (2021–2023), and most recently, Senior Vice President of U.S. Cardiovascular and Established Brands (2023–2024). Prior to BMS, Al worked with Andersen Consulting as an information technology and strategy consultant.
He is a member of the Board of Trustees of the Liberty Science Center in New Jersey.
Al earned his BS in Industrial Engineering and Operations from Cornell University and holds an MBA from the University of Michigan Business School.
Sessions
-
21st Century Access28-Oct-2025Schuyler Ballroom
){kind=logo}
)
)
){kind=logo}
)
){kind=logo}
)
)
){kind=logo}
)
)
)
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
)